131 related articles for article (PubMed ID: 824555)
1. Comparison of polymerized and unpolymerized antigen E for immunotherapy of ragweed allergy.
Metzger WJ; Patterson R; Zeiss R; Irons JS; Pruzansky JJ; Suszko IM; Levitz D
N Engl J Med; 1976 Nov; 295(21):1160-4. PubMed ID: 824555
[TBL] [Abstract][Full Text] [Related]
2. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
[TBL] [Abstract][Full Text] [Related]
4. Local intranasal immunotherapy with high-dose polymerized ragweed extract.
Georgitis JW; Nickelsen JA; Wypych JI; Barde SH; Clayton WF; Reisman RE
Int Arch Allergy Appl Immunol; 1986; 81(2):170-3. PubMed ID: 3759259
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
Casale TB; Busse WW; Kline JN; Ballas ZK; Moss MH; Townley RG; Mokhtarani M; Seyfert-Margolis V; Asare A; Bateman K; Deniz Y;
J Allergy Clin Immunol; 2006 Jan; 117(1):134-40. PubMed ID: 16387596
[TBL] [Abstract][Full Text] [Related]
6. Generation of antigen-specific suppressor cells during allergy desensitization.
Rocklin RE; Sheffer AL; Greineder DK; Melmon KL
N Engl J Med; 1980 May; 302(22):1213-9. PubMed ID: 6154241
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure.
Donovan JP; Buckeridge DL; Briscoe MP; Clark RH; Day JH
Ann Allergy Asthma Immunol; 1996 Jul; 77(1):74-80. PubMed ID: 8705641
[TBL] [Abstract][Full Text] [Related]
8. IgG and IgE antibody response following Pollinex-R immunotherapy.
Ko HS; Chen SJ; Jaworska E
Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
[TBL] [Abstract][Full Text] [Related]
9. The effect of immunotherapy on humoral and cellular responses in ragweed hayfever.
Evans R; Pence H; Kaplan H; Rocklin RE
J Clin Invest; 1976 May; 57(5):1378-85. PubMed ID: 57122
[TBL] [Abstract][Full Text] [Related]
10. The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis.
Grammer LC; Shaughnessy MA; Bernhard MI; Finkle SM; Pyle HR; Silvestri L; Patterson R
J Allergy Clin Immunol; 1987 Aug; 80(2):177-83. PubMed ID: 3301986
[TBL] [Abstract][Full Text] [Related]
11. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
13. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever.
Meriney DK; Kothari H; Chinoy P; Grieco MH
Ann Allergy; 1986 Jan; 56(1):34-8. PubMed ID: 2418713
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic problems before specific immunotherapy in patients with late-summer seasonal allergic rhinitis].
Kadocsa E
Orv Hetil; 1994 Sep; 135(36):1963-6. PubMed ID: 7936601
[TBL] [Abstract][Full Text] [Related]
17. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of 3 types of immunotherapy for treating grass pollen-induced allergic rhinitis].
Hébert J; Bédard PM
Allerg Immunol (Paris); 1986 Sep; 18(7):19-23. PubMed ID: 3453720
[TBL] [Abstract][Full Text] [Related]
19. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
[TBL] [Abstract][Full Text] [Related]
20. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
Yunginger JW; Gleich GJ
J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
